WHO approves Bavarian Nordic’s Mpox vaccine for adolescents
The World Health Organization (WHO) has approved Bavarian Nordic’s Jynneos mpox vaccine for adolescents aged 12 to 17 years, recognizing ...
The World Health Organization (WHO) has approved Bavarian Nordic’s Jynneos mpox vaccine for adolescents aged 12 to 17 years, recognizing ...
A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S's smallpox vaccine, marketed as Imvamune in Canada and ...